By Heather Blumenthal Dr. Uri Tabori holds positions as the head of the neuro-oncology program at the Hospital for Sick Children, a Professor of Paediatrics and Medical Biophysics at the University of Toronto, and a researcher at The Arthur and Sonia Labatt Brain Tumour Research Centre. To children with cancer whom he treats,… Read more »
Category: News
BioCanRx recognized as I.D.E.A.L. Bioscience Employer
The I.D.E.A.L. Recognition Program recognizes organizations in the Canadian bio-economy who embody the principles of inclusion, diversity, equity and accessibility leadership (IDEAL), as best practices needed to promote growth and success in the biotech sector. Learn more.
Summit4CI 2022: Back in-person & better than ever!
The long-awaited return of BioCanRx’s annual scientific conference finally came to fruition as scientists, patients, clinicians, trainees, and government and industry representatives joined together at Montréal’s Fairmont The Queen Elizabeth Hotel this past November 19-21. With a packed agenda offering plenaries, expert panels, social events and other networking opportunities, there was no time to… Read more »
Summit4CI 2022: The HQP Experience
By Charu Sankaran (BCCRI) and Shannon Snelling (University of Calgary), HQP Working Group members The 2022 Summit for Cancer Immunotherapy (Summit4CI) was held in Montréal, Québec, and was an incredible success. For many of the attendees, this was the first in-person conference since the pandemic. For many Highly Qualified Personnel (HQP), myself included, this… Read more »
Taking a Successful Training Approach to the National Level
By Heather Blumenthal Over the past four years, 20 people have participated in a unique partnership between the Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) and Ottawa’s Algonquin College that provides hands-on training to create the highly qualified personnel (HQP) needed to support the BMC’s important work. That partnership, known as the Canadian Partnership… Read more »
CSPC 2022: Interview with Stéphanie Michaud
CSPC 2022: Interview with Stéphanie Michaud
CSPC 2022 – Everything Old is New Again: Proven ingredients to successful mission-oriented program design from the NCE program
CSPC 2022 – Everything Old is New Again: Proven ingredients to successful mission-oriented program design from the NCE program
CSPC 2022 – Social Pharmaceutical Innovation: Made-in-Canada solutions to address unmet medical needs for advanced therapeutics
CSPC 2022 – Social Pharmaceutical Innovation: Made-in-Canada solutions to address unmet medical needs for advanced therapeutics
Summer Students Tell All
Another summer is already in the books, and that means that the undergraduate students who embarked on a BioCanRx-funded research internship in cancer immunotherapeutics have departed as well. We are so proud of the way they have learned and developed, and we extend our best wishes to them for the future! Curious what these… Read more »
Newmarket cancer patient credits made-in-Canada CAR T cell treatment in BioCanRx-funded clinical trial at The Ottawa Hospital for saving her life
In her fight with cancer, Newmarket resident Camille Leahy had to battle against more than just the disease. Diagnosed with acute lymphoblastic leukemia in January 2020, Leahy described the struggles of going through various treatments. After having a cancer resurgence in 2021 and being unable to bear the idea of another long chemotherapy treatment… Read more »
